Prostate Cancer, Version 3.2024
Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Cancer Institute (WIA) · +47 more institutions
Abstract
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
Citation impact
- FWCI
- 91.94
- Percentile
- 100%
- References
- 37
Authors
36- EMEdward M. SchaefferCorresponding
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- SSSandy Srinivas
Cancer Institute (WIA), Stanford Cancer Institute
- NANabil Adra
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University
- YAYi An
Yale Cancer Center, Smilow Cancer Hospital, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University
- RLRhonda L. Bitting
Cancer Institute (WIA), Duke Medical Center, Duke Cancer Institute
Topics & keywords
- Medicine
- Prostate cancer
- Risk stratification
- Disease
- Oncology
- Cancer
- Intensive care medicine
- Localized disease
- Good health and well-being